AI-generated summary
The authors evaluated a 589-nm solid-state laser for facial erythema in a prospective study of 24 participants who received four monthly treatments. Investigators and participants graded redness before each treatment and at follow-up, and the authors report a statistically significant but modest improvement, with side effects limited to transient posttreatment redness.
- Participants
- 24
- Who or what was studied
- 24 adults interested in treatment for facial erythema (16 women, 8 men, average age 51.1 years)
- Wavelengths
- 589 nm
- Limits stated in the abstract
- The abstract describes a small prospective study with no control group and reports only one follow-up point at 1 month after treatment.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.